Medifast (MED) Stock Analysis & Winston Score

Medifast is a US company that makes and sells weight loss and nutrition products. Its main brand is OPTAVIA, which offers meal replacement items like shakes, bars, and "fuelings" — pre-packaged low-calorie foods designed to help people lose weight. The company sells directly to everyday consumers who want a structured diet program. Medifast makes most of its money through a network of independent coaches — regular people who buy OPTAVIA products themselves and then sell them to friends, family, and clients. This coach-driven sales model keeps traditional advertising costs low but also creates risk, since revenue depends heavily on recruiting and retaining active coaches. The company operates almost entirely in the United States and has a market cap of roughly $100 million, a sharp drop from its peak. The rise of GLP-1 weight loss drugs like Ozempic is a serious threat, as many potential customers may choose medication over meal replacement programs instead.